{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:06:54Z","timestamp":1777378014399,"version":"3.51.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Human Cytomegalovirus (HCMV) infection may result in severe outcomes in immunocompromised individuals such as AIDS patients, transplant recipients, and neonates. To date, no vaccines are available and there are only few drugs for anti-HCMV therapy. Adverse effects and the continuous emergence of drug-resistance strains require the identification of new drug candidates in the near future. Identification and characterization of such compounds and biological factors requires sensitive and reliable detection techniques of HCMV infection, gene expression and spread. In this work, we present and validate a novel concept for multi-reporter herpesviruses, identified through iterative testing of minimally invasive mutations. We integrated up to three fluorescence reporter genes into replication-competent HCMV strains, generating reporter HCMVs that allow the visualization of replication cycle stages of HCMV, namely the immediate early (IE), early (E), and late (L) phase. Fluorescent proteins with clearly distinguishable emission spectra were linked by 2A peptides to essential viral genes, allowing bicistronic expression of the viral and the fluorescent protein without major effects on viral fitness. By using this triple color reporter HCMV, we monitored gene expression dynamics of the IE, E, and L genes by measuring the fluorescent signal of the viral gene-associated fluorophores within infected cell populations and at high temporal resolution. We demonstrate distinct inhibitory profiles of foscarnet, fomivirsen, phosphonoacetic acid, ganciclovir, and letermovir reflecting their mode-of-action. In conclusion, our data argues that this experimental approach allows the identification and characterization of new drug candidates in a single step.<\/jats:p>","DOI":"10.3389\/fcimb.2020.536150","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T16:02:10Z","timestamp":1610121730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A Novel Triple-Fluorescent HCMV Strain Reveals Gene Expression Dynamics and Anti-Herpesviral Drug Mechanisms"],"prefix":"10.3389","volume":"10","author":[{"given":"Ulfert","family":"Rand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Kubsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahram","family":"Kasmapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Cicin-Sain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/v12010110","article-title":"Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function","volume":"12","author":"Adamson","year":"2020","journal-title":"Viruses"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13166","article-title":"Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients","volume":"21","author":"Aryal","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1128\/aac.37.9.1945","article-title":"Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region","volume":"37","author":"Azad","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antiviral Res."},{"key":"B5","first-page":"1","article-title":"Synopsis of Clinical Aspects of Human Cytomegalovirus Disease","volume-title":"Cytomegaloviruses: From Molecular Pathogenesis to Intervention","author":"Boppana","year":"2013"},{"key":"B6","first-page":"26","article-title":"The Epidemiology and Public Health Impact of Congenital Cytomegalovirus Infection","volume-title":"Cytomegaloviruses: From Molecular Pathogenesis to Intervention","author":"Cannon","year":"2013"},{"key":"B7","doi-asserted-by":"publisher","first-page":"E10586","DOI":"10.1073\/pnas.1710522114","article-title":"Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency","volume":"114","author":"Cheng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2165\/00003495-199141010-00009","article-title":"Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis","volume":"41","author":"Chrisp","year":"1991","journal-title":"Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1056\/nejm199609053351007","article-title":"Ganciclovir","volume":"335","author":"Crumpacker","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1099\/0022-1317-82-5-1027","article-title":"The \u2018cleavage\u2019 activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring \u20182A-like\u2019 sequences","volume":"82","author":"Donnelly","year":"2001","journal-title":"J. Gen. Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41586-019-1369-y","article-title":"scSLAM-seq reveals core features of transcription dynamics in single cells","volume":"571","author":"Erhard","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2014.10.011","article-title":"Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle","volume":"113","author":"Gardner","year":"2015","journal-title":"Antiviral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/14656566.2019.1637418","article-title":"An overview of letermovir: a cytomegalovirus prophylactic option","volume":"20","author":"Gerna","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcv.2019.04.007","article-title":"New vaccines and antiviral drugs for cytomegalovirus","volume":"116","author":"Griffiths","year":"2019","journal-title":"J. Clin. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.antiviral.2011.01.007","article-title":"High-content screening to distinguish between attachment and post-attachment steps of human cytomegalovirus entry into fibroblasts and epithelial cells","volume":"89","author":"Ibig-Rehm","year":"2011","journal-title":"Antiviral Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01138-17","article-title":"Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors","volume":"92","author":"Kasmapour","year":"2017","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1099\/jgv.0.000713","article-title":"High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification","volume":"98","author":"Khan","year":"2017","journal-title":"J. Gen. Virol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/s1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1128\/jvi.64.4.1498-1506.1990","article-title":"Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins","volume":"64","author":"Malone","year":"1990","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1002908","DOI":"10.1371\/journal.ppat.1002908","article-title":"Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection","volume":"8","author":"Marcinowski","year":"2012","journal-title":"PloS Pathog."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00716-18","article-title":"Identification of Host Factors Involved in Human Cytomegalovirus Replication, Assembly, and Egress Using a Two-Step Small Interfering RNA Screen","volume":"9","author":"McCormick","year":"2018","journal-title":"mBio"},{"key":"B23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/IDR.S79131","article-title":"Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus","volume":"8","author":"Melendez","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"B24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1128\/AAC.42.4.971","article-title":"Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)","volume":"42","author":"Mulamba","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1128\/JVI.2.9.853-858.1968","article-title":"Enhancement of infectivity of murine cytomegalovirus in vitro by centrifugal inoculation","volume":"2","author":"Osborn","year":"1968","journal-title":"J. Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/00003495-199957030-00010","article-title":"Fomivirsen","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-62703-601-6_14","article-title":"Applications for a dual fluorescent human cytomegalovirus in the analysis of viral entry","volume":"1064","author":"Sampaio","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nmeth.2413","article-title":"A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum","volume":"10","author":"Shaner","year":"2013","journal-title":"Nat. Methods"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00013-18","article-title":"Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing","volume":"9","author":"Shnayder","year":"2018","journal-title":"MBio"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52168","article-title":"Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state","volume":"9","author":"Shnayder","year":"2020","journal-title":"eLife"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1099\/0022-1317-80-11-2867","article-title":"Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome","volume":"80","author":"Sinzger","year":"1999","journal-title":"J. Gen. Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1099\/vir.0.83286-0","article-title":"Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40\/E","volume":"89","author":"Sinzger","year":"2008","journal-title":"J. Gen. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1172\/JCI42955","article-title":"Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication","volume":"120","author":"Stanton","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Stern-Ginossar","year":"2012","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/JVI.26.3.686-701.1978","article-title":"Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides","volume":"26","author":"Stinski","year":"1978","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1517\/14712598.5.5.627","article-title":"Development of 2A peptide-based strategies in the design of multicistronic vectors","volume":"5","author":"Szymczak","year":"2005","journal-title":"Expert Opin. Biol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","article-title":"En passant mutagenesis: a two step markerless red recombination system","volume":"634","author":"Tischer","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1099\/vir.0.038083-0","article-title":"Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines","volume":"93","author":"Towler","year":"2012","journal-title":"J. Gen. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2014.04.028","article-title":"Quantitative temporal viromics: an approach to investigate host-pathogen interaction","volume":"157","author":"Weekes","year":"2014","journal-title":"Cell"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.536150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T04:08:01Z","timestamp":1610597281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.536150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":39,"alternative-id":["10.3389\/fcimb.2020.536150"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.536150","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"article-number":"536150"}}